Skip to main content
Premium Trial:

Request an Annual Quote

Cynthia Collins

Human Longevity has appointed Cynthia Collins as CEO. She replaces Craig Venter, who will remain at the company and serve as executive chairman of the board of directors. Collins comes to HLI from GE Healthcare, where she served as CEO and general manager for Cell Therapy and Purification and ANalysis Businesses. Before that she served as CEO of GE's Clarient Diagnostics. She has also held various executive positions at Genvec, Cellular Analysis Business Group, Sequoia Pharmaceuticals, and Clinical Microsensors (now Genmark).

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.